Open original FDA record ↗Recall record
- FDA identifier
- Z-2634-2011
- Company in FDA record
- RTI Biologics, Inc.
- FDA classification date
- Jun 23, 2011
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
RTI Biologics issued a recall of Osteofil DBM Paste, 5cc that was distributed on 03/04/2008 to one customer. The product was labeled as 5.0cc but should have been labeled as 0.5cc. All customers were notified of this recall on 04/09/2011.
Source facts
- Action
- RTI Biologics sent a "VOLUNTARY RECALL" letter dated April 9, 2008 to the one distributor, Spinal Graft Technologies. LLC. The letter describes the product, problem, and action to be taken by the distributor. The letter states that some of the product was issued a return authorization and requests that the distributor recover the remaining product from distribution. The recovered product will be issued a return authorization. RTI states the grafts can be returned in a non frozen state. Recall effectiveness will be determined by return of the product.
- Initiated
- 2011-04-09
- Root cause
- Labeling mix-ups
- Terminated
- 2012-07-24
- Distribution
- Domestic Distribution--TN only.
- Recall number
- Z-2634-2011
- Recall status
- Terminated
- CDRH record ID
- 100476
- FDA classified
- 2011-06-23
- Recall event number
- 58887